share_log

Wedbush Reiterates Outperform on Vor Biopharma, Maintains $11 Price Target

Moomoo 24/7 ·  Apr 23 13:24

Wedbush analyst David Nierengarten reiterates Vor Biopharma (NASDAQ:VOR) with a Outperform and maintains $11 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment